Hong Kong firm Uni-Bio Science Group and Swiss company Ypsomed to develop 'innovative' injection pens to treat diabetes and osteoporosis
SINGAPORE (May 5): Hong Kong-based Chinese healthcare group Uni-Bio Science Group announced Tuesday it is jointly developing two new biologic products to treat diabetes and osteoporosis.
……Read full article on The Edge Singapore - Latest News
News Singapore
One-stop lifestyle app dedicated to making life in Singapore a breeze!
English
简体中文
Comments
Leave a comment in Nestia App